INHBA is a prognostic predictor for patients with colon adenocarcinoma
Abstract Background Colon adenocarcinoma (COAD) is one of the most lethal cancers. It is particularly important to accurately predict prognosis and to provide individualized treatment. Several lines of evidence suggest that genetic factors and clinicopathological characteristics are related to cance...
Main Authors: | Xueying Li, Weiming Yu, Chao Liang, Yuan Xu, Miaozun Zhang, Xiaoyun Ding, Xianlei Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-06743-2 |
Similar Items
-
INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
by: Lyu S, et al.
Published: (2018-06-01) -
Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma
by: Jianwei Lin, et al.
Published: (2021-09-01) -
Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma
by: Jianjia Xiao, et al.
Published: (2021-01-01) -
Inhibin β-A (INHBA) induces epithelial–mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway
by: Yingying Yu, et al.
Published: (2021-01-01) -
Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients
by: Zhenxiang Rong, et al.
Published: (2020-02-01)